0001104659-23-088448.txt : 20230807
0001104659-23-088448.hdr.sgml : 20230807
20230807181145
ACCESSION NUMBER: 0001104659-23-088448
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230804
FILED AS OF DATE: 20230807
DATE AS OF CHANGE: 20230807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lucsok Anna
CENTRAL INDEX KEY: 0001843904
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38804
FILM NUMBER: 231148810
MAIL ADDRESS:
STREET 1: 9555 MAROON CIRCLE
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ZYNEX INC
CENTRAL INDEX KEY: 0000846475
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 870403828
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9655 MAROON CIRCLE
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
BUSINESS PHONE: (800)-495-6670
MAIL ADDRESS:
STREET 1: 9655 MAROON CIRCLE
CITY: ENGLEWOOD
STATE: CO
ZIP: 80112
FORMER COMPANY:
FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC
DATE OF NAME CHANGE: 20050812
FORMER COMPANY:
FORMER CONFORMED NAME: ZYNEX MEDICAL HOLDINGS INC
DATE OF NAME CHANGE: 20040120
FORMER COMPANY:
FORMER CONFORMED NAME: FOX RIVER HOLDINGS INC
DATE OF NAME CHANGE: 20031126
4
1
tm2323090-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-08-04
0
0000846475
ZYNEX INC
ZYXI
0001843904
Lucsok Anna
C/O ZYNEX, INC.
9655 MAROON CIRCLE
ENGLEWOOD
CO
80112
0
1
0
0
Chief Operating Officer
0
Common Stock
2023-08-04
4
S
0
12000
8.41
D
17840
D
Common Stock
2023-08-07
4
F
0
256
8.03
D
18275
D
On August 4, 2023, Anna Lucsok, sold an aggregate of 12,000 shares of common stock in open market transactions at a price per share equal to $8.41. The price per share equal to $8.41 represents the weighted average sales price for the shares. Upon request by the Commission, the Issuer or the Reporting Person shall provide full information regarding the number of shares sold at each separate price.
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of Restricted Stock Awards ("RSAs") and does not represent a sale.
/s/ Anna Lucsok
2023-08-07